Hellmann MD, Ott PA, Zugazagoitia J, et al. Nivolumab (nivo) ± ipilimumab (ipi) in advanced small-cell lung cancer (SCLC): First report of a randomized expansion cohort from CheckMate 032. J Clin Oncol. 35, 2017 (suppl; abstr 8503).
Immuuntherapie ook in de echte wereld succesvol bij gevorderd merkelcelcarcinoom
dec 2020 | Dermato-oncologie, Immuuntherapie